JayaBio News
Jaya Biosciences Receives U.S. Patent for Novel Methods of Treating Neurological Diseases, Including Alzheimer’s Disease, Expanding its Global Intellectual Property Portfolio
U.S. patent grant broadens protection and strengthens Jaya Biosciences’ leadership in developing CNS- directed therapies for genetically defined neurodegenerative diseases
Jaya Biosciences Receives Patent Notices of Allowance in Japan, China, and Singapore for Novel Methods of Treating Neurological Diseases, including Alzheimer’s
Patent allowances in Japan, China and Singapore support Jaya Biosciences’ commitment to addressing unmet needs in neurodegeneration in global markets
Jaya Biosciences Presents Updated Preclinical Data in Alzheimer’s Disease at the 45th SIMD Annual Meeting
Study results confirm potential utility of targeting lysosomal genes to treat neurodegenerative diseases, including Alzheimer’s disease
Jaya Biosciences Presents New Paradigm for the Treatment of Alzheimer’s Disease at the 23rd Annual Needham Virtual Healthcare Conference
Data presented highlight the potential utility of targeting lysosomal genes to treat neurodegenerative diseases, including Alzheimer’s
Jaya Biosciences Presents Promising Preclinical Data in Alzheimer’s Disease at the 20th Annual WORLDSymposium™ 2024
Study results highlight potential utility of targeting lysosomal genes to treat neurodegenerative diseases, including Alzheimer’s